Pfizer Inc. stock rises Friday, still underperforms market
Pfizer Inc. closed $8.04 short of its 52-week high ($36.94), which the company achieved on August 29th.
24/7 Wall St2d
Looking for $1500 in Safe Passive Income Each Year? Invest This Much in Pfizer.
Investors seeking safe dividend stocks may consider pharmaceutical giant Pfizer, which looks like a great passive ...
CBS News2d
FDA OK's new COVID vaccine shots for fall 2024 from Pfizer and Moderna
The Food and Drug Administration announced Thursday it has greenlighted updated COVID-19 vaccines from Pfizer and Moderna for the 2024 fall season. The decision clears the way for distribution to ...
Pfizer: Performance Is Improving, But Secular Issues Persist (Rating Upgrade)
We upgraded the rating for Pfizer (PFE) stock, citing positive trends within the company and in the market, despite recent drop after Q2 earnings. Learn more here.
Pfizer's Options Frenzy: What You Need to Know
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know. But ...
Pfizer and BioNTech's Combo Shot Missed the Mark. Is It Time to Sell?
A clinical-trial failure for Pfizer and BioNTech means Moderna is leading the race to develop a combo shot for the flu and ...
The Man Behind Pfizer’s Bid to Turn the Ship Around
Chris Boshoff, top oncology executive, counts on gains from the $43 billion Seagen merger.
Business Insider1d
Berenberg Bank Reaffirms Their Hold Rating on Pfizer (PFE)
Berenberg Bank analyst Kerry Holford maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $27.00. The company’s shares closed yesterday at $28.78. According to ...